Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

31 May 2022
Effectiveness of copper nanoparticle-based spray coating against SARS-CoV-2

Effectiveness of copper nanoparticle-based spray coating against SARS-CoV-2

31 May 2022
HIV research enables knowledge transfer for improved COVID-19 response

HIV research enables knowledge transfer for improved COVID-19 response

31 May 2022
SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

31 May 2022
COVID-19 lockdown restrictions impacted hospital admission rates throughout U.K.

COVID-19 lockdown restrictions impacted hospital admission rates throughout U.K.

31 May 2022
Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

30 May 2022
Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

30 May 2022
Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

30 May 2022
Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

30 May 2022
Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

30 May 2022
Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

30 May 2022
Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

30 May 2022
Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

30 May 2022
Study evaluates waning levels of protection against SARS-CoV-2 infection among recovered persons and uninfected BNT162b2 vaccinees

Study evaluates waning levels of protection against SARS-CoV-2 infection among recovered persons and uninfected BNT162b2 vaccinees

30 May 2022
Direct comparison of immune memory responses to four COVID-19 vaccines

Direct comparison of immune memory responses to four COVID-19 vaccines

30 May 2022
Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

30 May 2022
Researchers evaluate atovaquone as a COVID-19 treatment

Researchers evaluate atovaquone as a COVID-19 treatment

30 May 2022
Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

30 May 2022
Investigating post-COVID complaints after Delta versus Omicron variant infections

Investigating post-COVID complaints after Delta versus Omicron variant infections

30 May 2022
Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

30 May 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback